A Study of CAR-T Cells Targeting Autoimmune Diseases
ConditionAutoimmune Diseases
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Boren Hospital
About this trial
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in patients with autoimmune disease.
Eligibility criteria
Qualifiers
Male or female, between 18 and 56 years old;
Diagnosed with Autoimmune Diseases；
Good organ functions;
Voluntary participates this trial and can comprehend and sign ICF.
Disqualifiers
Had or has active malignancy;
Had been subjected to treatment by CD19 targeted therapy or CAR-T therapy or any gene therapy;
Combined with other autoimmune disease that needs treatment;
Pregnant or lactating women;
Trial design
Treatments tested in this trial
- CAR-T
Treatment groups
12 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov